Ovarian cancer is a serious illness that affects many women. A new review looks at a natural substance called isoliquiritigenin to see if it can help stop the disease. The findings show that this substance has significant effects against ovarian cancer cells. It works by inhibiting the growth of these cells. This means it can stop the cancer from spreading or getting worse. The review found that isoliquiritigenin has low toxicity. This means it is safe for the body and does not cause many side effects. It is a promising natural candidate for targeted therapy. It could also help reverse drug resistance in cancer cells. Doctors might use it in combination with other treatments to make them work better. While this review is positive, it is important to remember that more research is needed. The study did not report specific numbers of patients or exact timeframes. We must wait for larger trials to confirm these results before using this in real life. For now, the science looks hopeful but cautious.
Review suggests isoliquiritigenin may help fight ovarian cancer
Photo by Julia Koblitz / Unsplash
What this means for you:
Isoliquiritigenin shows promise as a safe, natural option to help treat ovarian cancer. More on Cancer
TEAS significantly reduces overall PONV risk in patients undergoing breast surgery compared to sham stimulation or routine care TEAS reduces nausea and pain for patients having breast surgery
Frontiers · Jun 4, 2026
Volume doubling time under 200 days marks all malignant nodules in 27 studies of lung cancer screening programs Nodule growth speed helps assess lung cancer risk in screening programs
Frontiers · Jun 4, 2026
Meta-analysis finds rheumatoid arthritis associated with increased thyroid cancer risk in pooled cohort data People with rheumatoid arthritis might have a higher chance of developing thyroid cancer in some groups
Frontiers · Jun 4, 2026
Combination therapy with 3M-052 and anti-TNFR2 antibody suppressed colon cancer growth in mouse models while enhancing immune response Early mouse study links antibody combo to slowed colon cancer growth
Frontiers · Jun 4, 2026